A phase 2 study of transcatheter aterial chemoembolization using cisplatin and DC beads for advanced hepatocellular carcinoma
Phase 2
Recruiting
- Conditions
- HCC
- Registration Number
- JPRN-UMIN000028000
- Lead Sponsor
- ational Hospital Organization KURE Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1)HCC without stain on angiogram. (2)History of hypersensitivity to cisplatinum-containing drug. (3)distant metastasis (4)main portal tumor thrombosis or hepatic vein tumor thrombosis (5)Patients with intrahepatic AP shunt or AV shunt. (6)Patients with complications to be treated preferentially. (7)Patients who can not keep their rest during the procedure. (8)Patients who are concluded to be inappropriate to participate in this study by their physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate(RR) 3 months after TACE
- Secondary Outcome Measures
Name Time Method Safty Tumor markers